Learn to track real recovery in major depressive disorder by monitoring mood, energy, cognition, and quality of life for ...

CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with ...

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...

Major depressive disorder (MDD) is a disturbance of mood that may have persistent and long-term consequences impacting patients’ overall level of functioning and quality of life. 1 Historically, ...

—Researchers recently examined the impact of depressive symptoms, as measured by the 21-item Beck Depression Inventory, on adherence to therapy using correlation, network analysis, and linear ...

Johnson & Johnson’s oral add-on drug significantly improved depressive symptoms and sleep outcomes in a phase 3 trial for patients who previously did not benefit from antidepressants alone. The ...

A large review adds weight to an old idea: movement can help ease depression. Here’s how to think about exercise as part of treatment and recovery.

"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...